Magenta Therapeutics
-$0.12 (-1.85%) Today
+$0.10 (+1.57%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MGTA and other ETFs, options, and stocks.
About MGTA
Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers patient preparation, stem cell collection, cell dose, and safe immune regeneration programs.
CEO
Jason Gardner
Employees
69
Headquarters
Cambridge, Massachusetts
Founded
2015
MGTA Key Statistics
Market Cap
373.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
118.26K
High Today
$6.57
Low Today
$6.29
Open Price
$6.49
Volume
146.39K
52 Week High
$14.20
52 Week Low
$5.89
Analyst Ratings
75%
of 8 ratings
Buy
75%
Hold
25%
Sell
0%
MGTA Earnings
-$0.51
-$0.34
-$0.17
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market